PICSAR
gene geneOn this page
Also known as NLC1-CPRED74lnc-NLC1-C
Summary
PICSAR (P38 inhibited cutaneous squamous cell carcinoma associated lincRNA, HGNC:19725) is a long non-coding RNA gene on chromosome 21q22.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19725 |
| Approved symbol | PICSAR |
| Name | P38 inhibited cutaneous squamous cell carcinoma associated lincRNA |
| Location | 21q22.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | NLC1-C, PRED74, lnc-NLC1-C |
| Ensembl gene | ENSG00000275874 |
| Ensembl biotype | lncRNA |
| OMIM | 617191 |
| Entrez | 378825 |
| RNAcentral | URS000075EA8F — lncRNA, 749 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000615826, ENST00000758108, ENST00000758109, ENST00000758110, ENST00000758111, ENST00000758112, ENST00000758113, ENST00000758114, ENST00000758115
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000615826 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004109850 | 44999140 | 44999656 |
| ENSE00004109852 | 45004444 | 45004753 |
Expression profiles
Bgee: expression breadth ubiquitous, 124 present calls, max score 74.77.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.5864 / max 54.2742, expressed in 113 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 190815 | 0.3047 | 83 |
| 190813 | 0.1210 | 51 |
| 190814 | 0.0984 | 49 |
| 190816 | 0.0623 | 36 |
Top tissues by expression
219 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 74.77 | gold quality |
| skin of leg | UBERON:0001511 | 73.03 | gold quality |
| skin of abdomen | UBERON:0001416 | 72.43 | gold quality |
| spinal cord | UBERON:0002240 | 71.66 | gold quality |
| right lung | UBERON:0002167 | 70.14 | gold quality |
| zone of skin | UBERON:0000014 | 69.00 | gold quality |
| left testis | UBERON:0004533 | 66.80 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.07 | gold quality |
| popliteal artery | UBERON:0002250 | 65.60 | gold quality |
| tibial artery | UBERON:0007610 | 65.56 | gold quality |
| aorta | UBERON:0000947 | 65.33 | gold quality |
| thoracic aorta | UBERON:0001515 | 65.30 | gold quality |
| ascending aorta | UBERON:0001496 | 65.18 | gold quality |
| testis | UBERON:0000473 | 64.14 | gold quality |
| left coronary artery | UBERON:0001626 | 63.76 | gold quality |
| mucosa of stomach | UBERON:0001199 | 63.24 | gold quality |
| lower esophagus | UBERON:0013473 | 62.93 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 62.92 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 62.89 | gold quality |
| right coronary artery | UBERON:0001625 | 62.78 | gold quality |
| coronary artery | UBERON:0001621 | 62.28 | gold quality |
| right testis | UBERON:0004534 | 61.54 | gold quality |
| upper lobe of lung | UBERON:0008948 | 61.08 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 60.56 | gold quality |
| calcaneal tendon | UBERON:0003701 | 57.08 | gold quality |
| gall bladder | UBERON:0002110 | 56.89 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 56.88 | gold quality |
| esophagus | UBERON:0001043 | 56.42 | gold quality |
| left uterine tube | UBERON:0001303 | 56.22 | gold quality |
| lung | UBERON:0002048 | 55.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.96 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 8)
- The accumulation of NLC1-C in the nucleus repressed miR-320a and miR-383 transcript and promoted testicular embryonal carcinoma cell proliferation by binding to Nucleolin. (PMID:26539909)
- PICSAR has a role in promoting cSCC progression via activation of extracellular signal-regulated kinase 1/2 signaling pathway by downregulating DUSP6 expression (PMID:27049681)
- LINC00162 overexpression increased the sensitivity, enhanced cell cycle arrest and apoptosis induced by 5-aza-dC, but did not affect its DNA demethylation effect. Mechanistically, LINC00162 interacted with an RNA splicing protein, HNRNPH1, and decreased splicing of an anti-apoptotic splicing variant, BCL-XL. LINC00162 may have translational value to predict patients who will respond to 5-aza-dC. (PMID:30914798)
- Our results reveal PICSAR may exert an essential role in promoting synovial invasion and joint destruction by sponging miR-4701-5p in RA and that lncRNA PICSAR may act as a biomarker of RA. (PMID:31791845)
- Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis. (PMID:32841663)
- LncRNA PICSAR binds to miR-485-5p and activates TGF-beta1/Smad to promote abnormal proliferation of hypertrophic scar fibroblasts (HSFs) and excessive deposition of extracellular matrix (ECM). (PMID:34255190)
- LINC00162 regulates cell proliferation and apoptosis by sponging PAQR4-targeting miR-485-5p. (PMID:35491694)
- Long Intergenic Non-Coding 00162 as Diagnostic Biomarker for Early-Stage Pancreatic Cancer. (PMID:36197769)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.